[Edaily Reporter Choi Hee-jae ] The movie "Paul 2: Dead Point" has reclaimed the top spot at the box office. "Lim Young-woong | I'm Hero: The Stadium 2," a live concert film featuring singer Lim Young-woong set to premiere tomorrow, continues to lead in advance ticket sales. Poster for the movie “Fall 2: Dead Point” (Photo courtesy of By Poem Studio) According to the Korean Film Council’s integrated computer network on the 17th, “Fall 2: Dead Point” drew 11,612 viewers as of the 16th, securing the No. 1 spot at the box office. Its cumulative audience stands at 151,649.
“Paul 2: Dead Point” is a film depicting an extreme survival struggle set on the cliffs of Mount Kwan, a mountain that has been off-limits for decades.
“The Final Interview” took second place with 7,592 viewers. Its cumulative attendance stands at 290,882. 'Chiikawa: The Secret of the Mermaid Island' (Chiikawa), which topped the box office last weekend, took third place with 6,144 viewers. Its cumulative attendance stands at 2,955,239, and it is on the verge of surpassing 3 million.
Next, “La La Land” took fourth place with 4,323 viewers, and “Heart of the Beast” took fifth with 3,576 viewers. The cumulative audience figures for these two films stand at 3,865,360 and 456,111, respectively.
In terms of advance ticket sales, Lim Young-woong’s concert film—set to open in one day—remains in first place. As of 8:03 a.m. that day, “Lim Young-woong | I’m Hero: The Stadium 2” ranked first in advance ticket sales with 55,048 tickets sold.
“Heavy Snow,” which opens on the same day, ranked second with 38,111 tickets sold. “The Hunger Games: The 50th Reaping” ranked third with 21,682 tickets, while “Chiikawa: The Secret of the Mermaid Island (Theatrical Version)” ranked fourth with 10,371 tickets. “La La Land” ranked fifth with 8,694 tickets.
NICE Credit Rating (NICE) ranked second in the credit rating reliability category of the 37th Edaily Survey of Credit Rating Experts (SRE). It was the only one of the three major credit rating agencie…
A poster presenting preclinical research on Regenotide, presented by NIBEC CO., LTD. at “ObesityWeek 2026” in Washington, D.C. The research team confirmed a reduction in fatty liver-related markers an…
AX specialist company MOCOMSYS(333050)(CEOs Kim In-soo and Yoon Young-ho) announced on the 17th that it recorded sales of 7.96 billion won in the third quarter of 2026, achieving its best quarterly pe…